Inconsistencies and time delays in site‐specific research approvals hinder collaborative clinical research in Australia
Victoria White(The University of Texas MD Anderson Cancer Center), Michael Coory(Government of Western Australia Department of Health), L. M. Orme(Peter MacCallum Cancer Centre), Rosemary Harrup(University of Tasmania), Kenton Thompson(Peter MacCallum Cancer Centre), Helen Bibby(Cancer Council Victoria), M.B. Phillips(Princess Margaret Hospital for Children), Antoinette Anazodo(Sydney Children's Hospital), Rachel Conyers(Royal Children's Hospital), Ross Pinkerton(Royal Marsden NHS Foundation Trust), Michael Osborn, Wayne Nicholls(Queensland Children’s Hospital), Monica Green(Murdoch Children's Research Institute)
Cited by 33
Related Papers
Major risk factors for stillbirth in high-income countries: a systematic review and meta-analysis
|The Lancet|2011|1.3k
Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
|Journal of Clinical Oncology|2016|867
Comprehensive Analysis of Hypermutation in Human Cancer
|Cell|2017|795
Stillbirths: recall to action in high-income countries
|The Lancet|2016|689